A Comprehensive Review on Schisandrin B and Its Biological Properties
- PMID: 32256947
- PMCID: PMC7102409
- DOI: 10.1155/2020/2172740
A Comprehensive Review on Schisandrin B and Its Biological Properties
Abstract
Nature is a vast source of bioactive molecules and has provided an active and efficient reservoir for drug discovery. Among natural compounds, one of the most promising is Schisandrin B (Sch B), isolated from Schisandra chinensis, which was documented to possess diversified pharmacokinetic propriety, among them antioxidant, anti-inflammation, cardioprotection, and neuroprotection. Due to its large biological properties, Sch B was recorded to be a potent cure for several diseases by targeting several signaling pathways. This review is aimed at emphasizing the recent data on the biological properties of Sch B among the molecular mechanism of this drug on tumoral, cardiac, and neural diseases. The data suggest that the antitumor activities of Sch B were mainly through apoptosis and cell cycle arrest at the diver's stage. It is reported that Sch B could be used as effective chemotherapy, neuroprotection, and cardioprotection since it possesses a spectrum of biological activities; however, further investigations on the mechanism of its action and preclinical trials are still mandatory to further validate the potential of this natural drug candidate.
Copyright © 2020 M. I. Nasser et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.J Am Soc Hypertens. 2017 Mar;11(3):148-157.e1. doi: 10.1016/j.jash.2016.12.007. Epub 2016 Dec 28. J Am Soc Hypertens. 2017. PMID: 28117274
-
Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing.Chem Biol Interact. 2019 Aug 25;309:108675. doi: 10.1016/j.cbi.2019.05.041. Epub 2019 May 28. Chem Biol Interact. 2019. PMID: 31150632
-
Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.Biomed Pharmacother. 2017 Dec;96:129-136. doi: 10.1016/j.biopha.2017.09.097. Epub 2017 Sep 30. Biomed Pharmacother. 2017. PMID: 28972885
-
A Review of Extraction and Purification, Biological Properties, Structure-Activity Relationships and Future Prospects of Schisandrin C: A Major Active Constituent of Schisandra Chinensis.Chem Biodivers. 2023 Dec;20(12):e202301298. doi: 10.1002/cbdv.202301298. Epub 2023 Dec 1. Chem Biodivers. 2023. PMID: 37990607 Review.
-
Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease.Oxid Med Cell Longev. 2016;2016:6171658. doi: 10.1155/2016/6171658. Epub 2016 Oct 26. Oxid Med Cell Longev. 2016. PMID: 27847552 Free PMC article. Review.
Cited by
-
In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice.Int J Mol Sci. 2023 Aug 18;24(16):12949. doi: 10.3390/ijms241612949. Int J Mol Sci. 2023. PMID: 37629132 Free PMC article.
-
A Novel Phaeoacremonium Species Isolated from Galls on the Chinese Magnolia-Vine (Schisandra chinensis) in Korea.Mycobiology. 2025 Feb 14;53(2):243-249. doi: 10.1080/12298093.2024.2438463. eCollection 2025. Mycobiology. 2025. PMID: 40098943 Free PMC article. Review.
-
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.Int J Biol Sci. 2024 Oct 14;20(14):5608-5672. doi: 10.7150/ijbs.98107. eCollection 2024. Int J Biol Sci. 2024. PMID: 39494333 Free PMC article. Review.
-
Experimental Studies of the Effect of Schisandrachinensis Extract on the State of Adaptive Capabilities of Rats under Chronic and General Exposure to Cold.Int J Environ Res Public Health. 2021 Nov 10;18(22):11780. doi: 10.3390/ijerph182211780. Int J Environ Res Public Health. 2021. PMID: 34831536 Free PMC article.
-
Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options.Naunyn Schmiedebergs Arch Pharmacol. 2021 Oct;394(10):2003-2011. doi: 10.1007/s00210-021-02132-z. Epub 2021 Aug 5. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34350498 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
